Login to Your Account



Genentech's Asthma Product, Xolair, Receives FDA Panel Nod

By Kim Coghill


Friday, May 16, 2003
An FDA advisory panel said Xolair appears to work well enough in moderate to severe allergic asthmatic patients to win regulatory approval. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription